These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9874490)

  • 21. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.
    Wicker LS; Appel MC; Dotta F; Pressey A; Miller BJ; DeLarato NH; Fischer PA; Boltz RC; Peterson LB
    J Exp Med; 1992 Jul; 176(1):67-77. PubMed ID: 1613467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
    Hussain S; Delovitch TL
    J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of cyclophosphamide treatment on lymphocyte subsets in the nonobese diabetic mouse: a comparison of various lymphoid organs.
    Zhang ZL; Georgiou HM; Mandel TE
    Autoimmunity; 1993; 15(1):1-10. PubMed ID: 8218826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
    Kim S; Kim KA; Hwang DY; Lee TH; Kayagaki N; Yagita H; Lee MS
    J Immunol; 2000 Mar; 164(6):2931-6. PubMed ID: 10706679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
    Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
    Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
    Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
    J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
    Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
    J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Christianson SW; Shultz LD; Leiter EH
    Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.
    Wicker LS; Miller BJ; Mullen Y
    Diabetes; 1986 Aug; 35(8):855-60. PubMed ID: 3525284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes.
    Balasa B; Van Gunst K; Sarvetnick N
    Clin Immunol; 2000 May; 95(2):93-8. PubMed ID: 10779402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary protection against diabetes in NOD mice: lack of a major change in the immune system.
    Hermitte L; Atlan-Gepner C; Payan MJ; Mehelleb M; Vialettes B
    Diabete Metab; 1995 Oct; 21(4):261-8. PubMed ID: 8529761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus.
    Gearon CL; Hussain MJ; Vergani D; Peakman M
    Diabetologia; 1997 Dec; 40(12):1388-95. PubMed ID: 9447945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.
    Qin HY; Sadelain MW; Hitchon C; Lauzon J; Singh B
    J Immunol; 1993 Mar; 150(5):2072-80. PubMed ID: 8436836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes resistance/susceptibility in T cells of nonobese diabetic mice conferred by MHC and MHC-linked genes.
    Ueno A; Cho S; Cheng L; Wang Z; Wang B; Yang Y
    J Immunol; 2005 Oct; 175(8):5240-7. PubMed ID: 16210629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice.
    Yagi H; Matsumoto M; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Eur J Immunol; 1992 Sep; 22(9):2387-93. PubMed ID: 1516628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
    Kaufman CL; Li H; Ildstad ST
    J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphoid hyperplasia, CD45RBhigh to CD45RBlow T-cell imbalance, and suppression of Type I diabetes mellitus result from TNF blockade in NOD-->NOD-scid adoptive T cell transfer.
    Brown GR; Silva MD; Thompson PA; Beutler B
    Diabetologia; 1998 Dec; 41(12):1502-10. PubMed ID: 9867218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide.
    Colucci F; Cilio CM; Lejon K; Gonçalves CP; Bergman ML; Holmberg D
    J Autoimmun; 1996 Apr; 9(2):271-6. PubMed ID: 8738973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
    Saï P; Rivereau AS
    Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.